购物车
- 全部删除
- 您的购物车当前为空
5-HT2B antagonist-1 是一种具有口服活性的5-HT2B 受体拮抗剂,IC50值为 33.4 nM。5-HT2B antagonist-1可用于以 5-HT2B 受体信号传导为特征的疾病研究,如肝细胞癌、心血管疾病或胃肠道疾病。
为众多的药物研发团队赋能,
让新药发现更简单!
5-HT2B antagonist-1 是一种具有口服活性的5-HT2B 受体拮抗剂,IC50值为 33.4 nM。5-HT2B antagonist-1可用于以 5-HT2B 受体信号传导为特征的疾病研究,如肝细胞癌、心血管疾病或胃肠道疾病。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 169 | 现货 | |
5 mg | ¥ 398 | 现货 | |
10 mg | ¥ 648 | 现货 | |
25 mg | ¥ 1,180 | 现货 | |
50 mg | ¥ 1,990 | 现货 | |
100 mg | ¥ 2,920 | 现货 | |
200 mg | ¥ 3,970 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 437 | 现货 |
产品描述 | 5-HT2B antagonist-1 is an orally active 5-HT2B receptor antagonist with an IC 50 of 33.4 nM. It can be used in studies of diseases characterized by 5-HT2B receptor signaling, such as hepatocellular carcinoma, cardiovascular disease or gastrointestinal disease [1] [2]. |
体外活性 | 5-HT2B antagonist-1 (compound 5g) has some sodium channel binding activity with IC 50 values ranging from 12.6 to 57.5 μM [1]. 5-HT2B antagonist-1 (coumpound 1-e) inhibits 5-HT2B receptor activity by less than 50% at 1 μM in CHO-K1 cell lines [3]. |
体内活性 | 5-HT2B antagonist-1 (compound 15) (oral gavage, 30 mg/kg) significantly reduces visceral hypersensitivity in irritable bowel syndrome (IBS) rats [2]. |
分子量 | 296.17 |
分子式 | C11H14BrN5 |
CAS No. | 393129-91-4 |
Smiles | CC1(C)NC(Nc2ccc(Br)cc2)=NC(N)=N1 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容